Jazz Pharmaceuticals Earnings
NASDAQ: JAZZHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Wed, Nov 4, 2026
Fiscal period
Sep/2026
EPS estimate
$5.66
Jazz Pharmaceuticals earnings summary
Jazz Pharmaceuticals is scheduled to report Sep/2026 earnings on Nov 4, 2026, with analysts expecting EPS of $5.66. In its most recent report on Aug 3, 2026 (Q2 2026), JAZZ posted EPS of $2.78. Revenue for the quarter was $1.21 billion.
Across the last 16 reports, JAZZ shares moved an average of 3.4% (in either direction) in the first trading session after results, rising 5 times and falling 11 times.
Summary generated from market data by MetaCap's automated system. Methodology
JAZZ earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 3, 2026 | — | $2.78 | — | -4.5% |
| May 5, 2026 | — | $4.43 | — | +1.3% |
| Feb 24, 2026 | — | $3.34 | — | -4.2% |
| Nov 5, 2025 | — | $4.08 | — | +7.6% |
| Aug 6, 2025 | — | $-11.74 | — | +5.8% |
| May 7, 2025 | — | $-1.52 | — | +11.5% |
| Feb 26, 2025 | — | $2.97 | — | -3.3% |
| Nov 7, 2024 | — | $3.42 | — | -1.6% |
| Aug 1, 2024 | — | $2.49 | — | -1.7% |
| May 2, 2024 | — | $-0.23 | — | -0.3% |
| Feb 28, 2024 | — | $1.40 | — | -1.1% |
| Nov 8, 2023 | — | $2.14 | — | +0.3% |
| Aug 9, 2023 | — | $1.52 | — | -0.6% |
| May 10, 2023 | — | $1.04 | — | -1.1% |
| Mar 1, 2023 | — | $-3.85 | — | -8.3% |
| Nov 9, 2022 | — | $-0.31 | — | -1.3% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.